Strides Pharma Science LtdNSE: STAR

Press Release Mar 21 2022

· Issued by Strides Pharma Science Ltd

Filed with NSE ·

Strides Pharma Science Limited has informed the Exchange about press release dated 21-Mar-2022 titled Strides partners with Medicines Patent Pool (MPP) to commercialize the generic version of Pfizer���s COVID-19 Oral Treatment across 95 markets

View Attachment

6ix hasn’t read this filing yet.

Strides Pharma Science Ltd on 6ix

Earlier from Strides Pharma Science

Later from Strides Pharma Science

All Strides Pharma Science news releases